CVSI - CV Sciences, Inc.
Region: US
Website: cvsciences.com
Employees: 70
IPO year: 2016
Issue type:
Market: OTCM
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
CV Sciences, Inc. operates as a life science company in North America. The Consumer Products segment develops, manufactures, and markets plant-based dietary supplements and hemp-based cannabidiol (CBD) products. The Specialty Pharmaceutical segment focuses on developing and commercializing cannabinoids to treat medical indications.
CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results
SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients ...
Read moreCV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based Foods
The innovative product line offers a unique choice of plant-based, 100% natural alternatives to the foods everyone loves. SAN DIEGO, CA / ACCESS Newswire / March 26, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" ...
Read moreCV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025
SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 20, 2025 /CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ...
Read more